Cubist Systematic Strategies, LLC Cytek Biosciences, Inc. Transaction History
Cubist Systematic Strategies, LLC
- $20.3 Billion
- Q2 2025
A detailed history of Cubist Systematic Strategies, LLC transactions in Cytek Biosciences, Inc. stock. As of the latest transaction made, Cubist Systematic Strategies, LLC holds 96,844 shares of CTKB stock, worth $391,249. This represents 0.0% of its overall portfolio holdings.
Number of Shares
96,844
Previous 57,413
68.68%
Holding current value
$391,249
Previous $230,000
43.04%
% of portfolio
0.0%
Previous 0.0%
Shares
11 transactions
Others Institutions Holding CTKB
# of Institutions
153Shares Held
74MCall Options Held
0Put Options Held
0-
Black Rock Inc. New York, NY17.1MShares$69 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA7.77MShares$31.4 Million0.0% of portfolio
-
Brown Capital Management LLC Baltimore, MD7.11MShares$28.7 Million0.72% of portfolio
-
Hhlr Advisors, Ltd. Grand Cayman, E96.66MShares$26.9 Million0.93% of portfolio
-
State Street Corp Boston, MA4.17MShares$16.9 Million0.0% of portfolio
About Cytek Biosciences, Inc.
- Ticker CTKB
- Exchange NASDAQ
- Sector Healthcare
- Industry Medical Devices
- Shares Outstandng 134,627,008
- Market Cap $544M
- Description
- Cytek Biosciences, Inc., a cell analysis solutions company, provides cell analysis tools that facilitates scientific advances in biomedical research and clinical applications. It offers aurora and northern lights systems, which are spectrum flow cytometers that delivers cell analysis by utilizing the fluorescence signatures from multiple lasers ...